Literature DB >> 21136978

Protein profiling of low-density lipoprotein from obese subjects.

Helen Karlsson1, Harriet Mörtstedt, Helen Lindqvist, Christer Tagesson, Mats Lindahl.   

Abstract

Although obesity and high levels of low-density lipoprotein (LDL) are well-known risk factors for cardiovascular disease, the precise role(s) of different LDL constituents in obesity has not been explored. In the present study, we compared the LDL proteome of healthy control adults (body mass index<25) and obese subjects (body mass index>30). LDL was isolated by density-gradient ultracentrifugation and proteins were separated with 2-D PAGE, quantified, and identified by peptide mass fingerprinting using MALDI-TOF MS. A new LDL-associated protein was identified as transthyretin and found to be significantly more abundant in LDL from the obese subjects. In addition, LDL from the obese subjects contained relatively more α(1) -antitrypsin, apo J, apo C-II, than LDL from controls, and also more of an acidic isoform (pI/Mr; 5.2/23 100) of apo A-I. On the other hand, the relative amounts of apo A-IV and the major isoform of apo A-I (pI/Mr; 5.3/23 100) were significantly less in LDL from the obese subjects. Apo E was less and non-sialylated apo C-III more abundant in LDL from obese men than control men, while there were no such differences between LDL from obese and control women. These findings illustrate that obesity is not only associated with increased LDL-cholesterol levels but also with alterations in the LDL protein composition. The presence of transthyretin in LDL from obese subjects may reflect over-nutrition and affect the lipid metabolism in obesity.
Copyright © 2009 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Year:  2009        PMID: 21136978     DOI: 10.1002/prca.200800138

Source DB:  PubMed          Journal:  Proteomics Clin Appl        ISSN: 1862-8346            Impact factor:   3.494


  4 in total

1.  Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatin.

Authors:  Nuntakorn Thongtang; Margaret R Diffenderfer; Esther M M Ooi; P Hugh R Barrett; Scott M Turner; Ngoc-Anh Le; W Virgil Brown; Ernst J Schaefer
Journal:  J Lipid Res       Date:  2017-04-09       Impact factor: 5.922

2.  A Comparative Analysis of the Lipoprotein(a) and Low-Density Lipoprotein Proteomic Profiles Combining Mass Spectrometry and Mendelian Randomization.

Authors:  Raphaëlle Bourgeois; Arnaud Girard; Nicolas Perrot; Jakie Guertin; Patricia L Mitchell; Christian Couture; Clarisse Gotti; Sylvie Bourassa; Paolo Poggio; Elvira Mass; Romain Capoulade; Corey A Scipione; Audrey-Anne Després; Patrick Couture; Arnaud Droit; Philippe Pibarot; Michael B Boffa; Sébastien Thériault; Marlys L Koschinsky; Patrick Mathieu; Benoit J Arsenault
Journal:  CJC Open       Date:  2020-12-03

Review 3.  Physical exercise, gut, gut microbiota, and atherosclerotic cardiovascular diseases.

Authors:  Jingyuan Chen; Yuan Guo; Yajun Gui; Danyan Xu
Journal:  Lipids Health Dis       Date:  2018-01-22       Impact factor: 3.876

4.  Plasma proteome correlates of lipid and lipoprotein: biomarkers of metabolic diversity and inflammation in children of rural Nepal.

Authors:  Sun Eun Lee; Kerry Schulze; Christine P Stewart; Robert N Cole; Lee S-F Wu; Abdulkerim Eroglu; James D Yager; John Groopman; Parul Christian; Keith P West
Journal:  J Lipid Res       Date:  2018-11-25       Impact factor: 5.922

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.